Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers


Cord Blood To The Rescue

A study in the Nov. 25 issue of The New England Journal of Medicine confirms that stem cells in blood extracted from the umbilical cords of newborns can help leukemia patients. Bone marrow from a relative continues to be the preferred source of stem cells, but each year some 16,000 patients in the U.S. fail to find such a match.

A team of researchers led by Dr. Mary J. Laughlin at the Ireland Cancer Center in Cleveland analyzed the outcomes of 600 leukemia patients who had received cord-blood transplants, bone marrow transplants from a relative, or bone marrow from a closely matched nonrelative. Patients who received bone marrow from relatives fared the best, with 33% of patients surviving the disease. But those who received cord blood did just as well as those who received bone marrow from an unrelated donor -- 22% of both groups survived. "This study should provide reassurance" to doctors using cord blood, says Laughlin.

By Catherine Arnst

EDITED BY Edited by Otis Port

blog comments powered by Disqus